EquityFlow
›
Companies
› Tenpoint Therapeutics
Tenpoint Therapeutics
Biotech
· Cambridge, GB
Biotech developing cell-based therapeutics to restore vision.
Funding history
Date
Round
Amount
Jul 2023
Series A
UK biotech Tenpoint Therapeutics raised a $70M Series A (British Patient Capital, F-Prime, Sofinnova).
$70M
Investors
British Patient Capital
F-Prime Capital
Sofinnova Partners
Similar companies in Biotech
Imperagen
Haga Bioscience
Pixelgen Technologies
Gallant
Chai Discovery
SNIPR Biome
Cellbox Labs
Scope Biosciences
GenLumina
Actithera
NUCLIDIUM
Anocca
Explore funding flow on EquityFlow →